Tesamorelin: A Growth Hormone Releasing Factor Analogue

Most compounds discussed in peptide research forums have never seen a phase-three trial. Tesamorelin has, which makes it unusually well documented and a useful yardstick for judging how much evidence actually stands behind other sequences.

The chemistry of a stabilised analogue

Growth hormone releasing hormone, GHRH, is a 44-residue hypothalamic peptide that signals the pituitary to release growth hormone in pulses. Native GHRH is cleared from circulation extremely quickly — a matter of minutes — largely through cleavage by dipeptidyl peptidase-4.

Tesamorelin is a synthetic analogue of the first 44 residues carrying a trans-3-hexenoyl group attached to the N-terminus. That single modification blocks the enzymatic cleavage site and substantially extends the molecule's working life. It is a textbook example of how a small chemical addition solves a pharmacokinetic problem without redesigning the sequence.

Analogue, not replacement

Because it acts upstream, at the GHRH receptor, the pituitary still governs the downstream pulse. That physiological difference — stimulating an existing axis rather than supplying the end hormone directly — is the mechanistic point researchers usually care about, and it is why the compound is grouped as a secretagogue rather than as a hormone.

What the clinical record shows

Tesamorelin was developed and studied specifically for HIV-associated lipodystrophy, and it holds regulatory approval in some jurisdictions for that indication. Trial publications describe changes in visceral adipose tissue measured by imaging, alongside monitored IGF-1 levels.

Laboratory handling

Tesamorelin is a longer chain than most compounds in this list and is correspondingly more delicate in solution. Handle it gently: no vortexing, no shaking, no repeated freeze-thaw of working aliquots.

1. 1Equilibrate the sealed vial to room temperature before opening.
2. 2Reconstitute slowly down the wall of the vial and swirl.
3. 3Aliquot if the protocol will span several sessions, rather than re-entering one vial repeatedly.
4. 4Keep everything refrigerated, dark and labelled with the reconstitution date.

Reading the documentation

For a 44-residue peptide, the chromatogram matters more than for a short sequence. Longer chains accumulate more synthesis-related impurities — deletion sequences in particular — and those show up as shoulders and satellite peaks rather than as a lower headline purity number. Ask to see the trace.